Prescription Drug News and Research

RSS

Calif. lawmakers advance nurse practitioner, pharmacist scope-of-practice bills

The legislation will likely rally opposition over care quality concerns, even as the nurse bill loses a key supporter.

16 Aug 2013

Longer looks: Fight against meth labs faces drug makers' opposition

Every week reporter Ankita Rao selects interesting reading from around the Web.

16 Aug 2013

CVS Caremark net revenues increase 1.7% in Q2 2013

CVS Caremark Corporation today announced operating results for the three months ended June 30, 2013.

6 Aug 2013

Medicare premiums hold the line -- increasing $1 in price from the past three years

The Obama administration cast the average monthly premium price increase as a matter of inches.

1 Aug 2013

First Edition: July 31, 2013

Today's headlines include reports that Medicare premiums will remain stable in 2014 and coverage of a new Congressional Budget Office estimate regarding the cost of delaying the health law's employer mandate.

31 Jul 2013

Obama administration touts slower health care cost increases

According to USA Today, personal health care costs rose at the slowest rate in the last 50 years, based on statistics for the past year ending in May.

31 Jul 2013

FDA acknowledges receipt of NDA resubmission of dapagliflozin drug for treatment of type 2 diabetes

AstraZeneca (NYSE: AZN) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for investigational drug dapagliflozin for the treatment of adults with type 2 diabetes.

26 Jul 2013

Viewpoints: It's time for Congress to talk about 'death panels;' Will health law opponents help constituents get coverage?

Probably nothing causes members of Congress more unease than having to talk about death. It's only been four years since healthcare reform became more about whether President Obama wanted to throw mama from a train via "death panels" than, well, how best to reform a broken healthcare system. Still, there are several representatives from both parties who want to discuss it (Daniel Rothberg, 7/22).

24 Jul 2013

GW Pharmaceuticals to expand marketing authorization for Sativex to France

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.

22 Jul 2013

House panel releases draft bill to repeal Medicare's payment system for doctors

The proposal would get rid of the sustainable growth rate formula and replace it with a system that rewards doctors based on quality and efficiency measures, MedPage Today reports.

20 Jul 2013

FDA grants orphan drug designation to ARMAGEN's AGT-182 for treatment of Hunter syndrome

ARMAGEN announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product AGT-182 for the treatment of mucopolysaccharidosis type II (also known as Hunter syndrome or MPS II).

19 Jul 2013

Viewpoints: Disability insurance 'time bomb;' Leavitt on the lessons of Medicare Part D's rollout; Boys and eating disorders

Social Security for retirement and Medicare are the best known of the major entitlement programs with looming financial disasters. While some argue about when they will run out of money, their projected 75-year unfunded liabilities grow larger every year and now total $40 trillion, much worse thereafter. But the ticking time bomb of entitlement reform is Social Security's Disability Insurance Fund (Michael J. Boskin, 7/14).

16 Jul 2013

Drexel University receives NIH grant to study medical marijuana use among LA young adults

Drexel University has received a grant for a five-year study of medical marijuana and its impact on drug use and physical and psychological health among young adults in Los Angeles. It is the first large-scale NIH project funded to directly investigate medical marijuana use among young adults aged 18 to 26.

15 Jul 2013

First Edition: July 12, 2013

Today's early morning highlights from the major news organizations, including articles on data tracking of doctors and comparing the rollout of the Medicare Part D drug plans to implementation of the federal health law.

12 Jul 2013

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.

11 Jul 2013

Restaurant owner welcomes delay on law’s insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

11 Jul 2013

First Edition: July 10, 2013

Today's early morning highlights from the major news organizations, including articles about House Republican plans to seek a delay in the health law's requirement that nearly all Americans get health insurance.

10 Jul 2013

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013.

9 Jul 2013

A few clinics are focused on helping pregnant women with prescription drug addictions

The Wall Street Journal examines the growing number of women addicted to pain killers and efforts to help them through pregnancies.